The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo.
暂无分享,去创建一个
R. Franco | S. Zappavigna | M. Caraglia | A. Barbieri | G. Palma | G. Scognamiglio | A. Luciano | D. Rea | C. Arra | P. Stiuso | A. Giudice | S. Perdoná | E. La Mantia | O. de Cobelli | M. Ferro | S. Bimonte
[1] Xi Chen,et al. Novel regulatory program for norepinephrine-induced epithelial–mesenchymal transition in gastric adenocarcinoma cell lines , 2014, Cancer science.
[2] T. Eubank,et al. The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer. , 2013, Cancer biomarkers : section A of Disease markers.
[3] Peter Kuhn,et al. Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. , 2013, Cancer research.
[4] Steve W. Cole,et al. Neuroendocrine influences on cancer progression , 2013, Brain, Behavior, and Immunity.
[5] Sandeep Robert Datta,et al. Behavioral stress accelerates prostate cancer development in mice. , 2013, The Journal of clinical investigation.
[6] V. Farini,et al. β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines , 2013, Laboratory Investigation.
[7] A. Baum,et al. Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts , 2013, Stress.
[8] Bruna Maria Rodrigues Vilardi,et al. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors , 2013, Tumor Biology.
[9] W. Muller. Regulate globally, act locally: adrenergic nerves promote leukocyte recruitment. , 2012, Immunity.
[10] A. Levine,et al. Chronic restraint stress attenuates p53 function and promotes tumorigenesis , 2012, Proceedings of the National Academy of Sciences.
[11] A. Abbruzzese,et al. Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth , 2012, Journal of cellular and molecular medicine.
[12] Steven W. Cole,et al. Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.
[13] Kunhong Xiao,et al. A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1 , 2011, Nature.
[14] A. Sood,et al. Stress Influences on Anoikis , 2011, Cancer Prevention Research.
[15] Anil K Sood,et al. Impact of stress on cancer metastasis. , 2010, Future oncology.
[16] A. Sood,et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. , 2010, Cancer research.
[17] M. Antoni,et al. Host factors and cancer progression: biobehavioral signaling pathways and interventions. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Q. Ma,et al. Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis Induction: The Study of &bgr;-Adrenoceptor Antagonist's Anticancer Effect in Pancreatic Cancer Cell , 2009, Pancreas.
[19] H. Schuller. Neurotransmission and cancer: implications for prevention and therapy , 2008, Anti-cancer drugs.
[20] J. Fiedler,et al. Stress promotes development of ovarian cysts in rats , 1998, Endocrine.
[21] K. Lang,et al. Neurotransmitter effects on tumor cells and leukocytes. , 2007, Progress in experimental tumor research.
[22] T. L. Drell,et al. The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockers , 2006, International journal of cancer.
[23] T. L. Drell,et al. Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. , 2006, Medical hypotheses.
[24] P. Sokołowska,et al. Constitutive activity of beta-adrenergic receptors in C6 glioma cells. , 2005, Pharmacological reports : PR.
[25] C. Kaltschmidt,et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs , 2004, International journal of cancer.
[26] Edna Maria Vissoci Reiche,et al. Stress, depression, the immune system, and cancer. , 2004, The Lancet. Oncology.
[27] Kerstin Lang,et al. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.
[28] T. L. Drell,et al. Effects of Neurotransmitters on the Chemokinesis and Chemotaxis of MDA-MB-468 Human Breast Carcinoma Cells , 2003, Breast Cancer Research and Treatment.
[29] K. Zänker,et al. Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. , 2003, Immunology letters.
[30] I. N. Reid,et al. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma , 2002, The Prostate.
[31] T. L. Drell,et al. Neurotransmitters are regulators for the migration of tumor cells and leukocytes , 2002, Cancer Immunology, Immunotherapy.
[32] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[33] K. Zänker,et al. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. , 2001, Cancer research.
[34] Liotta La. An attractive force in metastasis. , 2001 .
[35] G. Shakhar,et al. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. , 1998, Journal of immunology.
[36] D. Felten. Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system. , 1993, Neuropsychobiology.